End Taxpayer Funding of Gender Experimentation Act of 2021
- Last Action
- 5/18/2021
Actions
- 2021-05-18Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
- 2021-03-17Referred to the Subcommittee on Health.
- 2021-03-16Referred to the Subcommittee on Health.
- 2021-03-16Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-03-16Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-03-16Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 2021-03-16Introduced in House
- 2021-03-16Introduced in House
CRS Summary
As of 2021-03-16 (00)
End Taxpayer Funding of Gender Experimentation Act of 2021
This bill modifies provisions relating to federal funding for, and health insurance coverage of, gender reassignment medical interventions, which include surgical remedies and hormone therapy arising from a conflict between an individual's gender identity and the sex the individual has or was identified as having at birth. Specifically, the bill prohibits the use of federal funds for gender reassignment medical interventions or for health coverage that includes such interventions. Additionally, such interventions may not be provided in a federal health care facility or by a federal employee. Under current law, coverage of these interventions through Medicare and Medicaid is generally determined at the state level.
The bill's restrictions regarding the use of federal funds do not apply to treatment of individuals with medically verifiable disorders of sex development, such as individuals born with atypical development of chromosomal, gonadal, or anatomical sex.
The bill also prohibits qualified health plans from including coverage for gender reassignment medical interventions. Further, plans that include coverage for such interventions are not eligible for federal subsidies.
Cosponsors (20)
- Ralph Norman (R-SC)
- Rick Allen (R-GA)
- Glenn Grothman (R-WI)
- Jeff Duncan (R-SC)
- Doug Lamborn (R-CO)
- Jody Hice (R-GA)
- Mary Miller (R-IL)
- W. Steube (R-FL)
- Trent Kelly (R-MS)
- Jim Jordan (R-OH)
- Jim Banks (R-IN)
- Randy Weber (R-TX)
- ROBERT ADERHOLT (R-AL)
- Brian Babin (R-TX)
- Bob Good (R-VA)
- Lisa McClain (R-MI)
- Chip Roy (R-TX)
- Lauren Boebert (R-CO)
- Eric Crawford (R-AR)
- Matthew Rosendale (R-MT)
Subjects
- Appropriations
- Comprehensive health care
- Drug therapy
- Employee benefits and pensions
- Government buildings, facilities, and property
- Government employee pay, benefits, personnel management
- Health care costs and insurance
- Health care coverage and access
- Health facilities and institutions
- Health personnel
- Health programs administration and funding
- Income tax credits
- Sex and reproductive health
- Small business
- Surgery and anesthesia
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.